New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Denial Of Permanency To HIV-Positive Worker Unconstitutional: Bombay High Court
Mumbai Crime Year-Ender 2025: Digital Arrest Scams, Crimes Against Women And High-Profile Cases Keep City On Edge
Mumbai Fire Brigade Issues New Year Fire Safety Guidelines; Action Taken Against 122 Establishments
Mumbai News: Bandra Residents Alarmed As Trees Removed From CRZ-Protected Garden
